DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease.

DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease.

http://www.wikidata.org/entity/Q35438097

about

Arachidonic acid containing phosphatidylcholine increases due to microglial activation in ipsilateral spinal dorsal horn following spared sciatic nerve injury.Research on the traditional Chinese medicine treating gastrointestinal motility in diabetic rats by improving biomechanical remodeling and neuroendocrine regulation.MALDI mass spectrometric imaging meets "omics": recent advances in the fruitful marriage.Decrease in Sphingomyelin (d18:1/16:0) in Stem Villi and Phosphatidylcholine (16:0/20:4) in Terminal Villi of Human Term Placentas with Pathohistological Maternal Malperfusion.Oridonin Attenuates Synaptic Loss and Cognitive Deficits in an Aβ1-42-Induced Mouse Model of Alzheimer's Disease.Development of an Imaging Mass Spectrometry Technique for Visualizing Localized Cellular Signaling Mediators in Tissues.The use of MALDI-MSI in the investigation of psychiatric and neurodegenerative disorders: A review.Accumulation of arachidonic acid-containing phosphatidylinositol at the outer edge of colorectal cancer.Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model Increase in α-tubulin modifications in the neuronal processes of hippocampal neurons in both kainic acid-induced epileptic seizure and Alzheimer's disease.Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders.Presenilin-1 Targeted Morpholino Induces Cognitive Deficits, Increased Brain Aβ1-42 and Decreased Synaptic Marker PSD-95 in Zebrafish Larvae.Altered learning, memory, and social behavior in type 1 taste receptor subunit 3 knock-out mice are associated with neuronal dysfunction.Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic mice Anesthesia/Surgery Induces Cognitive Impairment in Female Alzheimer's Disease Transgenic Mice.Effect of APOE Genotype on Synaptic Proteins in Earlier Adult Life.Neuroprotective Actions of Dietary Choline.Synaptophysin depletion and intraneuronal Aβ in organotypic hippocampal slice cultures from huAPP transgenic mice.Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.Sevoflurane Acts on Ubiquitination-Proteasome Pathway to Reduce Postsynaptic Density 95 Protein Levels in Young Mice.Impact of dietary fats on brain functions.Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review

P2860

Q33724859-63F18279-53DA-4F5C-831F-A8370C82985B Q33733145-1195EC1C-52FB-4769-9F6C-78D92E5BDD4E Q35687880-EFCA4F08-4DB7-4E28-BC15-42B823366CBF Q35841852-AA26C302-7FD5-4736-8394-1D56F1073D9E Q35956077-EF9BDE60-E2A1-4737-B393-D36DA4EAB0BA Q35969085-5161328A-CB5F-489D-AD81-1D98D6D4E117 Q36052708-166AA28A-A22E-4250-9013-7FE4B70C25B8 Q36082169-95D5A1F7-AAB1-40CB-A2CB-0DCCFC36228F Q36867296-FFC0B48A-9EE5-4D51-9B38-E47FD06101C7 Q37571252-D5F79901-61CD-49CF-A379-6BE1F30B2EF3 Q37694175-5B387337-3900-45D3-B2BC-F8C712559CB4 Q38721567-EAD47876-17F1-4CBD-9E8C-ADCD3053F235 Q38776050-B8B251A8-4361-4DFD-B1AF-BFAA601D12FA Q38795375-D01F30EC-8939-4A07-9344-9F9A60043073 Q38922817-70FD73E4-16AA-43C1-A176-42EE8C9936DA Q41273331-E2F7309B-F102-4927-AFA4-DEF19CA97A97 Q41583852-C0CF8BEB-F841-4BE1-89B8-EEAE4F53B565 Q41841473-BA6C8E2E-06E5-41CE-870B-25777D53B9AF Q42655692-CBABBE2C-F6B9-4B96-87C3-122841F35B04 Q46830133-138F7175-B12B-404C-9999-7A55C6E8899D Q47246868-08CE19BA-8620-469A-B8AE-394522399831 Q47290017-D54FD99A-477E-4715-A264-DCE3BABD667C Q58549216-1F5E97DF-FE72-415A-92E5-D5E4FDB1CB8B

P2860

DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease.

http://www.wikidata.org/entity/Q35438097

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

DHA-PC and PSD-95 decrease aft ...... ents with Alzheimer's disease.

@ast

DHA-PC and PSD-95 decrease aft ...... ents with Alzheimer's disease.

@en

type

label

DHA-PC and PSD-95 decrease aft ...... ents with Alzheimer's disease.

@ast

DHA-PC and PSD-95 decrease aft ...... ents with Alzheimer's disease.

@en

prefLabel

DHA-PC and PSD-95 decrease aft ...... ents with Alzheimer's disease.

@ast

DHA-PC and PSD-95 decrease aft ...... ents with Alzheimer's disease.

@en

P1433

Q35438097-9E7E57C3-60AF-4AD7-A1A0-3DB7BC9EDD23

P1476

Q35438097-D7C73DBF-579C-4989-A809-3EAB7B2E282F

P2093

Q35438097-02703C56-0810-4A63-9041-508245066F18

Q35438097-1501D4C0-289F-44CC-B40F-C4AE30CFF8BE

Q35438097-1B5938E0-7DC5-47D1-9CE1-573E0CEDB4B3

Q35438097-3CC277A9-8E40-446D-A366-C0198F66ECDE

Q35438097-3D5A0CA4-EF18-47EE-96A3-E857C686014A

Q35438097-445E43A4-AB59-4AED-93BA-18BB5E1E4098

Q35438097-5AF15C06-A459-4299-AD93-EACA5D8725EA

Q35438097-651954EC-CFC8-4C42-B42B-F431356EAACA

Q35438097-767AC68B-B5E7-4343-9BBB-50E27AB1C30F

Q35438097-B6927676-309E-4B15-94BE-64EEA3827D45

P2860

Q35438097-01E236B4-2938-4D06-9418-667D8E9F3855

Q35438097-01F0045B-844D-4CC3-99DD-FC92552E1E99

Q35438097-05396A14-8228-40EB-87D7-E3364C25FF40

Q35438097-05949F72-5C06-47DE-AD48-B6D6419403E5

Q35438097-08A7D001-116C-4363-825B-F08A9D21537A

Q35438097-0C135D48-81B3-406C-8AC6-37E8CD4EEAE7

Q35438097-0DE98CE5-6279-49E7-BC32-8805C7BF2753

Q35438097-0E83D65D-C3EC-41A7-940B-03487B4BD1E1

Q35438097-0FF390BA-0E1F-43C0-8B98-B7D3EAA29ED7

Q35438097-2009B05D-2029-41DE-AFBB-989A31FC324F

P2888

Q35438097-C8AFABDD-CB17-4E04-891A-2DF4B607F25D

P304

Q35438097-017B05FF-F13C-4CFC-96FC-15218674DE01

P31

Q35438097-3A6E74C6-1F28-4771-97FC-CEC5447535F9

P356

Q35438097-44C1665C-E066-4F96-A8F9-4F469A41DB83

P407

Q35438097-6A8FA27E-4153-4AF5-BD0A-123175664D40

P478

Q35438097-0B220CC4-B7B0-4208-AB31-E42C999B2BD4

P577

Q35438097-A30AE7F4-A2F8-4802-B3D7-A8450E0E5B3A

P5875

Q35438097-BE0357D6-3586-4840-83C9-F50AB803A8D1

P6179

Q35438097-E185A445-1536-4303-AD6D-3FB5DDC8DB3B

P698

Q35438097-9C0A73B9-F339-4F4A-86F5-696B4F28F58B

P921

Q35438097-10C6DEFB-C3AD-4ECD-A8FA-ABA9464675B2

P932

Q35438097-83A475B0-B4DB-4208-A54D-25B0F6564524

P356

P1433

Scientific Reports

P1476

DHA-PC and PSD-95 decrease aft ...... ents with Alzheimer's disease.

@en

P2093

Ayae Kinoshita

http://www.w3.org/2001/XMLSchema#string

Dai Yuki

http://www.w3.org/2001/XMLSchema#string

Hiroyasu Akatsu

http://www.w3.org/2001/XMLSchema#string

Ikuko Yao

http://www.w3.org/2001/XMLSchema#string

Keikichi Sugiyama

http://www.w3.org/2001/XMLSchema#string

Masato Maesako

http://www.w3.org/2001/XMLSchema#string

Mitsutoshi Setou

http://www.w3.org/2001/XMLSchema#string

Nobuhiro Zaima

http://www.w3.org/2001/XMLSchema#string

Ryo Kon

http://www.w3.org/2001/XMLSchema#string

Shiro Takei

http://www.w3.org/2001/XMLSchema#string

P2860

Mass spectrometric analysis reveals changes in phospholipid, neutral sphingolipid and sulfatide molecular species in progressive epilepsy with mental retardation, EPMR, brain: a case study

A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease

Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus

A simple method for the isolation and purification of total lipides from animal tissues

Neuropathological stageing of Alzheimer-related changes

Phospholipase A2 biochemistry

Evidence for a membrane defect in Alzheimer disease brain

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment

P2888

P304

7130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP07130

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268789882

http://www.w3.org/2001/XMLSchema#string

P6179

1028363014

http://www.w3.org/2001/XMLSchema#string

P698

25410733

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5382699

http://www.w3.org/2001/XMLSchema#string